Browsing: Bacterial > Clostridium Difficile Infection

C. difficile news and research

Clostridium difficile is a bacterium commonly associated with hospital-acquired infections and among those who have recently taken antibiotics.

Pathology & Pathogenesis

14 June, 2018 0 Organoids: a new model to study infectious diseases?

Recent technological advancements have allowed organoids to become a viable research tool for a wide range of development and disease models. Here, we look at some of the research that’s been done in infectious diseases and delve into what the future of organoids might look like.

Clostridium Difficile Infection

20 February, 2018 0 Microbiome therapeutics – the pipeline for C. difficile infection

We take a look at the key microbiome therapeutics currently in the clinical pipeline for recurrent C. difficile infections and their prospects for the treatment of this disease in the future.

Bacterial

15 February, 2018 1 Infographic: The microbiome and infectious diseases

In our latest infographic we provide a visual snapshot of the infections and immune processes that have been linked with the microbiome thus far, explaining some of the evidence

Antimicrobial Resistance

15 November, 2017 0 World Antibiotic Awareness Week – a quick-fire interview with Jonathan Cooke

As part of our focus around World Antibiotic Awareness Week (13–19 November) we spoke to Professor Jonathan Cooke, a pharmacologist and pharmacist based in the UK who holds a special interest in antimicrobial resistance. He shares his thoughts on this pressing issue below:

Drug Development

13 November, 2017 0 Infographic: A summary of the antibacterial agents in clinical development

In this infographic we summarize the clinical candidates reported by the WHO – indicating which diseases they are active (or possibly active) against, whether they’re considered innovative and which Phase the trials are currently in.

Antimicrobial Resistance

20 September, 2017 0 Is the world going to run out of antibiotics?

A new report from the WHO has highlighted the lack of innovative new antibiotic treatments currently in the clinical pipeline, and has emphasized this as a concern in the face of rising antimicrobial resistance.

Clostridium Difficile Infection

5 July, 2017 0 Are cases of recurrent Clostridium difficile infection on the rise in the United States?

An analysis of a large, nationwide health insurance database reveals a rapid increase in multiple recurring Clostridium difficile infections in the United States.

Clostridium Difficile Infection

23 April, 2017 0 ECCMID17: DNA fingerprinting suggests food may be a source of C. difficile

In research presented at ECCMID 2017, scientists have suggested foods should be investigated as potential source of C. difficile.

Antimicrobial Resistance

10 April, 2017 0 Inhibition of MRSA and of Clostridium difficile by durancin 61A: synergy with bacteriocins and antibiotics

This study delves aims to evaluate the efficacy of durancin 61A as an inhibitor of resistant clinical pathogens and to shed light on its mode of action.

Clostridium Difficile Infection

9 February, 2017 0 New study suggests that vancomycin should be the antibiotic of choice for Clostridium difficile infections

A study including over 10,000 patients has demonstrated a lower risk of all-cause 30-day mortality when Clostridium difficile infections are treated with vancomycin as opposed to metronidazole.

1 2 Next